Biopharmaceutical Alliances: Forging Partnerships That Work

Friday, November 9, 2007 General News J E 4
CHAPEL HILL, N.C., Nov. 8 As biotech companies continue togenerate a growing portion of the biopharmaceutical industry's drug pipelineand pharmaceutical companies seek more efficient pathways to develop, marketand sell innovative products, managers and executives are finding it crucialto examine potential alliances and how to create, develop and execute theirstrategic plans to ensure successful partnerships.

Too often those partnerships fail due to mismanaged negotiations, poorpreparation and suboptimal execution. According to a recent study bypharmaceutical research and consulting firm Best Practices, LLC interviewingveteran co-promotion and co-alliance executives, deals are successful whenthey focus on creating win-win situations for both entities.

"Profitable Partnerships: Developing Excellence in Alliances," availablewith a complimentary report excerpt at, examines how the business developmentexecutives at biotechnology and pharmaceutical companies view success inalliance creation, development and execution.

It explains insights from business development executives on strengths andweaknesses in deal making and execution. This study explores the winningstrategies and practices of nine pharmaceutical and biotech companies thathave engaged in successful strategic alliances.

Among the questions answered in this study (read more in the downloadableexcerpt):

Download a complimentary report summary of "Profitable Partnerships:Developing Excellence in Alliances," at

If you have questions about this report or would like to speak to us abouthow our research can benefit your current initiatives in your company, pleasecontact Cameron Tew, Manager of Research and Publishing at Best Practices, LLCat (919) 767-9246 or


Best Practices, LLC, conducts work based on the simple yet profoundprinciple that organizations can chart a course to superior economicperformance by studying the best business practices, operating tactics andwinning strategies of world-class companies. Best Practices, LLC has been aleader in pharmaceutical research and consulting for nearly 15 years; ourclients include 43 out of the top 50 pharmaceutical companies.-- What are the decisions that need to be made when beginning the partnering process? -- How can a partnership be used most strategically? -- What do you ask for in a licensing/co-promotion deal?

SOURCE Best Practices, LLC


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
BioCryst Reports Third Quarter 2007 Financial Resu...
Global Diabetes Summit Attracts World-Renowned Exp...